Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib with or without nefopam for postoperative opioid use after ACL reconstruction
TCTR20250413001Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Etoricoxib alone with Etoricoxib + nefopam (2 arms). Primary endpoint: Postoperative opioid analgesic consumption. Started Oct 2024; status: recruiting.
02
Drugs
etoricoxibnefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20250413001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250413001.